Literature DB >> 3883501

Chemotherapy and combined modality therapy for locally advanced and metastatic gastric carcinoma.

T Le Chevalier, F P Smith, W K Harter, P S Schein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883501

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  7 in total

1.  Adjuvant chemotherapy in gastric cancer.

Authors:  P Schlag
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

Review 2.  External beam plus intraoperative irradiation for gastrointestinal cancers.

Authors:  L L Gunderson; D M Nagorney; J A Martenson; J H Donohue; G R Garton; H Nelson; J Fieck
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

3.  Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract.

Authors:  A S Goldenberg; D Kelsen; J Dougherty; G Magill
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

4.  Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose schedule.

Authors:  V Gebbia; R Valenza; A Testa; C Sciume; A Longo; C Cipolla; N Borsellino; P Leo; M Latteri; M Florena
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 5.  Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer.

Authors:  Chiara Arienti; Sara Pignatta; Anna Tesei
Journal:  Front Oncol       Date:  2019-11-26       Impact factor: 6.244

6.  Advanced gastric carcinoma chemotherapy with cisplatin, mitomycin C, BCNU, and 5-fluorouracil in combination.

Authors:  R H Kim; Y W Lee; D C Lee; N H Kim; J S Choi; S K Joo; C S Kim
Journal:  Korean J Intern Med       Date:  1987-01       Impact factor: 2.884

7.  Enhancement of cytotoxicity of cisplatin in vitro by recombinant human tumor necrosis factor and/or recombinant human interferon-alpha, -beta and -gamma.

Authors:  C M Kim; W S Hong; J O Lee; T W Kang; Y W Kim; J K Song; T K Yun; C Y Kim
Journal:  Jpn J Cancer Res       Date:  1989-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.